SEOUL, South Korea, Dec. 9, 2025 /PRNewswire/ -- MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can distinguish single-base mismatches ...

The pitch is compelling: a single sample of blood could scan the body for dozens of different cancers at once, catching disease at a stage when it is easier to treat and more likely to be curable. For ...

Cancer begins when mutations in specific genes override the body’s built-in controls on cell division, allowing rogue cells ...

Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...

Yesterday, the U.S. Food and Drug Administration approved the first blood-based genetic test that can detect gene mutations in non-small cell lung cancer patients. The cobas EGFR Mutation Test v2 is a ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by the extremely low levels of tumor-derived DNA ...

BRCA1 and BRCA2 gene mutations increase the risk of hereditary breast cancer. Here's what you should know about the causes, genetic testing options, and prevention strategies to manage your cancer ...

A study explains how broken DNA during cell division can trigger chromoanasynthesis when two repair pathways combine, causing erratic copying and large DNA duplications, offering potential targets for ...

The cancer diagnostics industry is evolving rapidly as advances in biotechnology, data analytics and precision medicine ...

Cervical cancer is among the more preventable cancers for people with a cervix, yet many myths and misunderstandings persist that can affect screening behaviors and hinder early detection. Clarifying ...